Skip to main content

Dentsply Sirona Value Stock - Dividend - Research Selection

Dentsply sirona

ISIN: US24906P1093 , WKN: A2AF0E

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Dental Giant DENTSPLY SIRONA Inc. (XRAY) Keeps Wellspect Unit Amid Strong Market Potential

2025-09-16
In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. DENTSPLY SIRONA Inc. is one of them. DENTSPLY SIRONA Inc. (NASDAQ:XRAY), the world’s largest manufacturer of professional dental products and technologies, operates across imaging, CAD/CAM, endodontics, restoratives, and healthcare consumables through Wellspect. Its product portfolio includes intraoral scanners, […]

DENTSPLY SIRONA (XRAY) Retains Wellspect Business Citing Greater Value for Shareholders

2025-09-12
DENTSPLY SIRONA (XRAY) recently decided to retain its subsidiary Wellspect Healthcare, believing in its potential for greater value generation. This, alongside the decision to enhance operational efficiency under new CEO Dan Scavilla, coincided with a 6.82% rise in the company's share price over the last month. While the broader market saw gains, driven by tech sector strength and speculation of interest rate cuts, DENTSPLY SIRONA's strategic focus on its core business likely provided...

Dentsply Sirona Retains Wellspect Following Strategic Review

2025-09-10
XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.

DENTSPLY SIRONA Inc. (XRAY) Presents At Baird 2025 Global Healthcare Conference (Transcript)

2025-09-09
Discover Dentsply Sirona's turnaround strategy: increased R&D, U.S.

DENTSPLY SIRONA Inc. (XRAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

2025-09-08
Discover Dentsply Sirona's new leadership strategy, growth plans, R&D focus, and 2025-26

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives

2025-09-08
Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the CompanyCHARLOTTE, N.C., Sept. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company has completed the evaluation of strategic alternatives for its Wellspect Healthcare business (“Wellspect”), which was announced in February 2025. As a part of its review process, Dentsply Sirona considered a range of potenti

3 Reasons to Avoid XRAY and 1 Stock to Buy Instead

2025-09-08
Over the past six months, Dentsply Sirona’s shares (currently trading at $14.70) have posted a disappointing 8.4% loss, well below the S&P 500’s 15.5% gain. This might have investors contemplating their next move.

Returns Are Gaining Momentum At DENTSPLY SIRONA (NASDAQ:XRAY)

2025-09-05
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Dentsply Sirona (XRAY) Q2 2025 Earnings Transcript

2025-09-02
Before we begin, please take a moment to read the forward-looking statements in our earnings press release. During today's call, we may make certain forward-looking statements that reflect our current views about future performance and financial results. On today's call, our remarks will be based on non-GAAP financial results.

Dental Implants Market Forecasts from 2025 to 2030 | Rising Dental Disorders and Innovations from Industry Leaders Such As Institut Straumann AG and Dentsply Sirona Spur Expansion

2025-08-29
The Dental Implants Market is poised to grow from USD 7.778 billion in 2025 to USD 10.728 billion by 2030 at a CAGR of 6.64%. This comprehensive market study analyzes trends, technological advancements, and competitive strategies, providing insights into key drivers like rising dental disorders and innovations from industry leaders such as Institut Straumann AG and Dentsply Sirona. Dental Implants Market Dental Implants Market Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "Dental Implants Market